D68.2 Hereditary deficiency of other clotting factors

Name of the Condition

• Hereditary Deficiency of Other Clotting Factors

Summary

Hereditary deficiency of other clotting factors is a genetic bleeding disorder caused by insufficient levels or dysfunction of specific coagulation factors, excluding more commonly recognized deficiencies like factor VIII (hemophilia A) or von Willebrand factor. This condition impairs the blood’s ability to form clots, leading to abnormal bleeding tendencies.

Causes

The condition is inherited through genetic mutations affecting the production or function of specific clotting factors. These mutations are typically passed down in an autosomal recessive or dominant pattern, depending on the factor involved. The deficiency may result from reduced synthesis, abnormal structure, or impaired activity of the affected factor.

Risk Factors

• Family history of bleeding disorders or unexplained bleeding episodes.
• Inherited genetic mutations in genes encoding specific clotting factors.
• Consanguinity (parents who are closely related), increasing the risk of recessive inheritance.
• Ethnic or regional prevalence for certain factor deficiencies (e.g., factor XI deficiency in Ashkenazi Jews).

Symptoms

• Prolonged bleeding from minor cuts or injuries.
• Excessive bruising with minimal trauma.
• Spontaneous nosebleeds or gum bleeding.
• Heavy or prolonged menstrual bleeding (menorrhagia) in women.
• Bleeding into joints or muscles (hemarthrosis or hematomas) in severe cases.
• Excessive bleeding during or after surgery or dental procedures.

Diagnosis

Diagnosis involves a combination of clinical evaluation, family history, and laboratory testing. Specific factor activity assays are used to identify the deficient factor and quantify its level. Additional tests may include prothrombin time (PT) or activated partial thromboplastin time (aPTT) to assess overall clotting function, followed by targeted factor testing to confirm the specific deficiency.

Treatment Options

Treatment focuses on replacing the deficient clotting factor to control bleeding. This may involve:

• Infusions of the specific recombinant or plasma-derived clotting factor.
• Desmopressin (DDAVP) for certain factor deficiencies (e.g., mild factor VIII or von Willebrand disease).
• Antifibrinolytic agents (e.g., tranexamic acid) to stabilize clots.
• Avoidance of medications that impair clotting (e.g., aspirin, NSAIDs).

Prognosis and Follow-Up

Prognosis varies depending on the severity of the deficiency and the specific factor involved. Mild deficiencies may cause minimal symptoms, while severe deficiencies can lead to life-threatening bleeding. Regular follow-up with a hematologist is essential to monitor factor levels, adjust treatment, and manage complications. Prophylactic factor replacement may be recommended for high-risk individuals.

Complications

• Chronic joint damage from recurrent bleeding (hemophilic arthropathy).
• Life-threatening bleeding (e.g., intracranial hemorrhage).
• Anemia due to excessive blood loss.
• Delayed wound healing or surgical complications.

Lifestyle & Prevention

• Avoid activities with high risk of injury (e.g., contact sports).
• Use protective gear (e.g., helmets, padding) during physical activities.
• Inform healthcare providers about the condition before procedures or surgeries.
• Maintain good dental hygiene to reduce bleeding risks.
• Consider genetic counseling for family planning.

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Uncontrolled bleeding from an injury.
• Signs of internal bleeding (e.g., severe pain, swelling, dizziness).
• Excessive bleeding during or after surgery or dental work.
• New or worsening bruising without obvious trauma.

Tips for Medical Coders

When coding for hereditary deficiency of other clotting factors, ensure the documentation specifies the exact factor deficiency (e.g., factor XI, XII) and confirms the hereditary nature. Verify that the diagnosis aligns with the clinical presentation and laboratory results. Document any factor replacement therapy or prophylactic measures, as these may impact coding specificity. Avoid coding for acquired deficiencies unless explicitly stated, as the code D68.2 is reserved for hereditary conditions.